Leerink Partners Downgrades Imprivata (IMPR) to Market Perform; Doesn't See Cerner (CERN) Making Competing Bid

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. NVDA
2. CRWV
3. SPY
4. BAC
5. BLK
6. RKLB
7. CAT
8. AA
9. MRSH
10. RSG

Go back to Leerink Partners Downgrades Imprivata (IMPR) to Market Perform; Doesn't See Cerner (CERN) Making Competing Bid

Imprivata Agrees to Be Acquired by Thoma Bravo

July 13, 2016 8:00 AM EDT

Thoma Bravo to pay $19.25 per share, representing a 33% premium to Imprivatas stock price

Transaction valued at approximately $544 million

SAN FRANCISCO & LEXINGTON, Mass.--(BUSINESS WIRE)-- Imprivata® (NYSE: IMPR), the healthcare IT security company, announced that it has entered into a definitive agreement to be acquired by an affiliate of Thoma Bravo, LLC, a leading private equity investment firm. Under the terms of the agreement, shareholders of record will receive $19.25 in cash per share of Imprivata common stock, which represents a 33% premium to Imprivatas last closing... More